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Microglia are believed to be the only resident immune cells in the central 
nervous system (CNS), originating from hematopoietic-derived myeloid cells and 
invading the CNS during development.  However, the detailed mechanisms of 
differentiation and transformation of microglial cells are not fully understood.  
Here, we demonstrate that murine microglial cells show 2 morphological forms in 
vitro, namely, small round cells expressing CD11b, Iba1, triggering receptor 
expressing on myeloid cells-2 (TREM2), and weakly expressing major 
histocompatibility complex (MHC) class II and large flat cells expressing only 
CD11b and Iba1.  Moreover, lineage-negative bone marrow (LN) cells cultured 
with primary mixed glial culture cells could differentiate into only the small round 
microglia-like cells despite the absence of CCR2 and Gr-1 expression.  Addition 
of macrophage colony stimulating factor (M-CSF) to LN cell culture allowed the 
proliferation and expression of TREM2 in LN cells, and the addition of 
neutralizing anti-M-CSF antibodies suppressed the proliferation of LN cells 
despite the expression of TREM2.  When LN cells were cultured with M-CSF, 
the number of small round cells in the culture was considerably low, indicating 
that the small round morphology of the immature cells is not maintained in the 
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presence of only M-CSF.  On the other hand, when LN cells were grown in the 
presence of astrocytes, the small round cells were maintained at a concentration of 
approximately 30% of the total population.  Therefore, cell-cell contact with 
glial cells, especially astrocytes, may be necessary to maintain the small round 
shape of the immature cells expressing TREM2. 
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Introduction 
Microglia are believed to be the only resident immune cells in the central 
nervous system (CNS); they develop from hematopoietic-derived myeloid cells 
and invade the CNS during development (Ling & Wong, 1993).  Microglial cells 
are recognized to play an important role not only in neuroinflammatory and 
neurodegenerative diseases such as multiple sclerosis and Alzheimer’s disease but 
also in neuroprotective and anti-neuroinflammatory processes (Akiyama & 
McGeer, 2004; Sanders & De Keyser, 2007; Takahashi et al., 2007).  In a recent 
study, it has been reported that physiological microglial phagocytosis induced the 
efficient removal of apoptotic cells and cellular debris without inflammatory 
processes; this process is expected to be a novel, attractive target for protection 
from neuroinflammation or neurodegeneration (Takahashi et al., 2005, 2007; 
Neumann & Takahashi, 2007).  The detailed mechanisms underlying the 
differentiation and transformation of microglial cells, however, are not fully 
understood.  Even in adulthood, hematopoietic-derived cells develop into 
resident perivascular macrophages and microglia (Hickey & Kimura, 1988; Priller 
et al., 2001; Simard & Rivest, 2004).  Although the exact cellular subtype of 
myeloid precursors that develop into microglia is unknown, it has been reported 
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that only Ly-6ChighCCR2+ monocytes can invade and differentiate into 
perivascular microglia (Mildner et al., 2007).  
  The bone marrow produces new blood cells, including all cell types of the 
myeloid lineage, some of which may differentiate into microglia.  
Lineage-negative bone marrow (LN) cells are defined by the absence of surface 
markers such as CD3, CD4, CD5, CD8α, CD11b/MAC-1α, B220, Gr-1, and 
TER-119 and are considered to comprise many hematopoietic precursors, 
including microglia precursors.  Thus, LN cells might represent microglial 
precursors and may serve as a natural vehicle for CNS cells in gene therapy.   
  In this study, we show that murine microglial cells are present in vitro in 2 
morphological forms, namely, as small round cells expressing CD11b, Iba1, 
triggering receptor expressing on myeloid cells-2 (TREM2), and weakly 
expressing major histocompatibility complex (MHC) class II and as large flat cells 
expressing only CD11b and Iba1.  We found that LN cells could differentiate 
into the small round-type but not the large flat-type microglia-like cells.  
Moreover, we concluded that not only macrophage colony-stimulating factor 
(M-CSF) but also cell-cell contacts with astrocytes play an important role in 
microglial differentiation. 
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Materials and Methods 
Isolation of LN cells from adult GFP mice bone marrow 
Bone marrow cells were collected from 8- to 10-week-old C57BL/6 mice 
(Charles River, Japan) or green fluorescence protein (GFP) transgenic mice on a 
C57BL/6 mice background that were kindly provided by Dr. Masaru Okabe 
(Osaka University, Japan) by flushing out the femora and tibiae of the hind limb.  
Erythrocyte removal was performed by lysis with the Mouse Erythrocyte Lysing 
Kit (R&D, Minneapolis, MN).  For eliminating lineage marker-positive cells via 
negative selection, bone marrow cells were incubated at 4°C for 30 min with 8 
types of rat monoclonal antibodies against mice lineage markers (CD3, CD4, CD5, 
CD8α, CD11b/MAC-1α, B220, Gr-1, and TER-119 (R&D)).  The cells were then 
washed and incubated with immunomagnetic beads (Invitrogen, Tokyo, Japan) at 
4°C for 30 min.  Finally, LN cells were collected by the removal of 
lineage-positive bone marrow cells by using a magnet stand that attracted the 
lineage marker-positive cells attached to the antibodies.  
All experiments were approved by the Ethics Committee of Kanazawa 
University and performed in accordance with the guidelines of the local animal 
care and use committee of Kanazawa University. 
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Primary mixed glial cell culture  
Microglial cells were prepared from the brains of postnatal days 3–5 
(P3–P5) of C57BL/6 mice as previously described (Takahashi et al., 2005).  
Briefly, meninges were removed mechanically, and the cells were dissociated by 
trituration and cultured in basal medium Eagle (BME; Invitrogen), 10% fetal calf 
serum (FCS; Invitrogen), 1% glucose (Sigma, Tokyo, Japan), 1% L-glutamine 
(Invitrogen), and 1% penicillin/streptomycin (Invitrogen) for 14 d to form a 
confluent glial monolayer.  LN bone marrow cells obtained from GFP mice were 
added onto the confluent glial monolayer.  
 
Treatment of LN cell culture with mixed glial cell culture supernatant, neutralizing 
antibodies, or cytokines 
LN cells were cultured with the mixed glial cell culture supernatant obtained 
from the day-14 primary mixed glial culture.  LN cells were also cultured with a 
culture medium containing M-CSF (10 ng/ml, Peprotech, Rocky Hill, NJ), tumor 
necrosis factor-α (TNF-α; 10 ng/ml, Peprotech), or vascular endothelial growth 
factor (VEGF; 50 ng/ml, Peprotech) for 7 d.  For the neutralizing assay, 
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anti-M-CSF (2 μg/ml, R&D), anti-TNF-α (2 μg/ml, R&D), or anti-VEGF (1 μg/ml, 
R&D) antibodies were added in the LN cell culture for 7 d.  
 
Immunohistochemistry  
Mixed glial cell cultures with or without GFP-positive (GFP+) LN cells 
were fixed in 4% paraformaldehyde for 1 h, blocked by Protein Block (Dako, 
Denmark) for 2 h, and then immunostained with monoclonal rat antibodies 
directed against CD11b (Serotec, Oxford, UK) and a secondary fluorescence 
rhodamine-conjugated antibody directed against rat IgG (1:200, Millipore, 
Billerica, MA).  To identify the cell type, cells were double-labeled with a 
purified polyclonal sheep antibody directed against TREM2 (1:50, R&D), 
monoclonal rabbit antibodies directed against Iba1 (Wako, Kanagawa, Japan), and 
glial fibrillary acidic protein (GFAP; Dako) and monoclonal mouse antibodies 
directed against IAb (BD Pharmingen, Tokyo, Japan), followed by a secondary 
fluorescein isothiocyanate (FITC)-conjugated antibody directed against mouse 
IgG.  Images were collected by fluorescence microscopy with a 20× objective 
(Olympus, Tokyo, Japan).  A confocal microscope with a 40× objective (Zeiss, 
Jena, Germany) was used to obtain z-stack images, and series of optical sections 
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(512 × 512 pixels, pixel size: 440 nm) were collected at intervals of 380 nm.  
Images were analyzed using the Zeiss LSM Image browser (Zeiss). 
To quantify the number of cells, 10 fields under the 20× objective were 
randomly selected and photographed by fluorescence microscopy using a digital 
camera (Olympus) for each experiment.  Total cells, GFP-positive cells, and 
positively immunostained cells were classified and counted according to their 
morphology.  
 
Isolation of microglia and splenic macrophages 
Microglial cells and GFP+ LN cells-derived microglial cells in primary 
mixed glial culture were obtained by shaking the flasks at 150 rpm for 2 h.  
Adult CNS microglia and splenic macrophages were obtained from GFP mice.  
The cortex and spinal cord of GFP mice were isolated and homogenized.  
Homogenates were incubated with 0.3 Wunsch units/ml Liberase Blendzyme 3 
(Roche, Tokyo, Japan) and 0.1 mg/ml DNaseI (Roche) in RPMI 1640 medium at 
37°C for 30 min.  Microglia were separated through a density gradient.  The 
cells were suspended in 27% Percoll (GE Healthcare, Tokyo, Japan) and overlaid 
with a 72% gradient.  The density gradient was centrifuged at 2,800 rpm for 30 
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min at 4°C.  Myelin collected in the 27% Percoll layer was removed.  The 
majority of microglia were found in the interface of the 27% and 72% Percoll 
layers.  Cells were obtained from this interface and washed from the Percoll with 
phosphate buffered saline (PBS).  The spleen was isolated and cut into small 
fragments.  Cells were incubated with 0.3 Wunsch units/ml Liberase Blendzyme 
3 (Roche) and 0.1 mg/ml DNaseI (Roche) in RPMI 1640 medium at 37°C for 45 
min.  Erythrocyte removal was performed using ACK solution.  
 
Flow cytometry analysis of LN cells, microglia, and splenic macrophages 
For flow cytometry analysis, cells were first incubated for Fc-receptor 
blockade by CD16/CD32 antibody (BD Pharmingen) and then stained with 
PE-conjugated anti-IAb antibody and anti-CD45 antibody (BD Pharmingen), 
PerCP-Cy5.5-conjugated anti-CD11b antibody (BD Pharmingen), 
APC-conjugated anti-TREM2 antibody (R&D) and anti-F4/80 antibody 
(eBioscience, San Diego, CA), or purified anti-CCR2 antibody (Abcam, Tokyo, 
Japan) followed by rhodamine-conjugated anti-Goat IgG (Millipore, Billerica, 
MA).  Analysis was performed with a FACSCalibur flow cytometer (BD 




Microglial cells and GFP+ LN cells-derived microglia-like cells in primary mixed 
glial culture, adult CNS microglia, and splenic macrophages were cultured with 
various concentrations of M-CSF (0–100 ng/ml), and cultures were pulsed with 1 
mCi of [3H]TdR (MP Biomedicals, Tokyo, Japan) for the last 16 h of the 
incubation.  Cell incorporation of [3H]TdR was counted with a Topcount (Perkin 
Elmer, Boston, MA).  The mean cpm of triplicate cultures was calculated.  
 
Stimulation by anti-TREM2 antibody 
Small round cells were added to culture dishes coated with the anti-TREM2 
monoclonal antibody (R&D) or control antibody and centrifuged at 1500 
rpm for 5 min.  After 60 min, the cells were fixed at a final concentration of 
4% formaldehyde for 10 min at 37 °C.   Following centrifugation, the 
supernatant was removed, and the cells were resuspended in 90% ice-cold 
methanol and incubated for 30 min at 4°C.  Cells were washed and stained 
with Alexa 647-conjugated anti-phospho-ERK1/2 antibody (Cell Signaling 




Bio-Plex Cytokine Assay System 
Culture supernatant samples were analyzed simultaneously for 17 different 
cytokines and chemokines (IL-1b, IL-2, IL-4, IL-5, IL-10, GM-CSF, IFN-γ, 
TNF-α, IL-15, IL-18, FGF-basic, LIF, M-CSF, MIG, MIP-2, PDGF-BB, and 
VEGF) using the Bio-Plex Cytokine Assay System (Bio-Rad Laboratories, 
Hercules, CA) according to the manufacturer’s instructions.  Briefly, 50 μl of 
each sample and standard (Bio-Rad) were added to 50 μl of antibody-conjugated 
beads (Bio-Rad) in a 96-well filter plate (Millipore).  After 30-min incubation, 
the plate was washed, and 25 μl of a biotinylated antibody solution (Bio-Rad) was 
added to each well, followed by 30-min incubation again.  The plate was washed, 
and 50 μl of streptavidin-conjugated phycoerythrin (PE; Bio-Rad) was added to 
each well and incubated for 10 min.  After a final wash, the contents of each well 
were resuspended in 125 μl of assay buffer (Bio-Rad) and analyzed using a 
Bio-Plex Array Reader (Bio-Rad).  The lower detection limit for each cytokine 




Data are presented as mean ± S.D. of at least three independent 




Characterization of microglia in the primary mixed glial culture 
To characterize microglial cells in the mixed glial culture, we stained several 
microglia markers such as Iba1, CD11b, TREM2, and IAb (MHC class II 
molecule of C57/BL6 mice) on the cultured microglial cells (Fig. 1A).  
CD11b-positive (CD11b+) cells in the primary mixed glial culture showed two 
major morphological forms, namely, small round-shaped cells (32.8 ± 6.9% S.D. 
of CD11b+ cells) expressing Iba1, TREM2, and IAb (Iba1+ cells, 91.9 ± 10.2% 
S.D.; TREM2+ cells, 97.5 ± 3.5% S.D.; IAb+ cells; 88.9 ± 19.2% S.D.) and large 
flat cells (67.2 ± 6.9% S.D. of CD11b+ cells) expressing only Iba1 (Iba1+ cells, 
81.1 ± 2.6% S.D.; TREM2+ cells, 3.3 ± 1.1% S.D.; IAb+ cells, 6.4 ± 2.8% S.D.; 
Iba1 vs. TREM2, P = 0.0495; Iba1 vs. IAb, P = 0.0495) (Fig. 1B, C).  
Z-sectioned scans by confocal microscopy revealed that small, spherically shaped 
cells lay above the astrocytes, and large flat cells lay under the astrocytes (Fig. 
1D).  Moreover, the spherical cells appeared to have extended processes toward 
the astrocytes (Fig. 1E).  
To investigate the time point at which both the forms of the microglial cells 
appeared in the primary mixed glial culture, we performed a kinetic study.  At 
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day 1 after the culture of mixed glial cells, CD11b+ cells showed a small 
amoeboid shape (Fig. 1F).  At day 3, the CD11b+ cells assumed a larger flat 
shape.  Small round CD11b+ cells were very few in number until day 5 (day 3, 
1.9 ± 1.1% S.D.; day 5, 2.7 ± 0.9% S.D.) but increased greatly after day 7 (day 7, 
10.9 ± 1.1% S.D., vs. day 3, P = 0.0495; day 14, 32.8 ± 6.9% S.D., vs. day 3, P = 
0.0495) (Fig. 1F, G).  
 
Characteristics of LN cells 
LN cells were isolated by negative selection using magnet beads.  The 
purity of LN cells after negative selection by flow cytometry was consistently 
above 90% on several examinations (Fig. 2A).  LN cells expressed neither the 
microglia marker TREM2 nor CD11b, which is one of the lineage markers for 
negative selection (Fig. 2B).  No expression of CCR2 or Gr-1 (lineage markers 
for negative selection) was detected on the LN cells, which have previously been 
described as markers of microglial precursors (Fig. 2B).  IAb, which is an MHC 
class II antigen, was negative on the surface of the LN cells.   
 
Differentiation of LN cells into microglia-like cells 
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LN cells obtained from GFP mice were co-cultured with primary mixed glial 
cells for 2 weeks.  Two weeks after the co-culture, the cells were stained by 
anti-TREM2, anti-Iba1, anti-MHC class II, and anti-CD11b antibodies, followed 
by rhodamine- or Cy3-conjugated secondary antibodies (Fig. 3A).  GFP+ cells 
showed 2 major morphologies, i.e., small and round cells with bright nuclei (27.7 
± 7.9% S.D. in GFP+ cells) and flat cells with dark nuclei (69.9 ± 6.9% S.D. in 
GFP+ cells), similar to the microglia in the primary mixed glial cells seen in Fig. 
1.  Most of the small round cells were TREM2-, Iba1-, CD11b-, and IAb-positive 
(TREM2+ cells, 92.7 ± 1.9% S.D.; Iba1+ cells, 93.6 ± 1.6% S.D.; CD11b+ cells, 
96.5 ± 3.1% S.D.; IAb+ cells, 84.6 ± 13.4% S.D.) (Fig. 3B) and were spherically 
shaped along the z-axis (Fig. 3C).  On the other hand, flat cells expressed none 
of the following: CD11b, Iba1, TREM2, or IAb (TREM2+ cells, 6.5 ± 3.9% S.D.; 
Iba1+ cells, 3.5 ± 1.0% S.D.; CD11b+ cells, 9.3 ± 3.7% S.D.; IAb+ cells, 3.9 ± 
1.9% S.D.).  Since TREM2/DAP12 signaling is known to induce ERK 
phosphorylation in immature dendritic cells, we analyzed the 
phosphorylation of ERK using flow cytometry after cross-linking stimulation 
of LN cell-derived small round cells in order to determine whether the 
TREM2 on small round cells was functional.  Stimulation of TREM2 of the 
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LN cell-derived small round cells induced phosphorylation of ERK as 
demonstrated by a specific antibody recognizing the phosphorylated form of 
ERK (Fig. 3D).
In the kinetic study, GFP+ LN cells were immunostained at days 1, 7, and 14 
after co-culturing with primary mixed glial cells with anti-TREM2 and anti-Iba1 
antibodies followed by secondary antibodies.  At day 1, LN cells had already 
differentiated into 2 morphological groups—small round cells expressing Iba1 and 
TREM2 and flat amoeboid cells (Fig. 3E).  Interestingly, the ratio of LN 
cell-derived small round and flat cells remained identical at day 1 and day 7 but 
reduced at day 14 (day 1, 45.7 ± 2.5% S.D.; day 7, 41.7 ± 1.9% S.D., vs. day 1, P 
= 0.0495; day 14, 29.5 ± 6.4% S.D., vs. day 1, P = 0.0495) (Fig. 3F).  
 
Analysis of surface cell markers and proliferative capacity of LN cell-derived 
small round cells 
In many publications, not only the expression of CD11b, Iba1, and F4/80 but 
also low expressions of CD45 and MHC class II have been used as microglial 
markers.  Among them, low expressions of CD45 and MHC class II are one of 
the most important resting microglial markers.  We measured the quantitative 
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expression of CD45 and MHC class II on brain microglia, cultured microglia, and 
LN cell-derived small round cells.  As shown in Figure 4A, LN cell-derived 
small round cells showed low expressions of CD45 and MHC class II, which was 
identical to results for cultured and brain microglia as compared to those for 
spleen-derived macrophages.  LN cell-derived small round cells were also F4/80 
positive, which is known to be another microglial marker.   
Since microglia can continue to proliferate and differentiate to macrophages, 
we investigated the proliferative capacity of brain microglia and LN cell-derived 
small round cells with various concentrations of M-CSF, and compared this 
capacity to that of splenic macrophages.  LN cell-derived small round cells 
showed increased incorporation of [3H] thymidine similar to that by brain 
microglia, but [3H] thymidine incorporation by splenic macrophages did not 
increase in a low concentration of M-CSF (1 ng/ml) (LN cell-derived small 
round cells vs. splenic macrophages, P = 0.0495; brain microglia vs. splenic 
macrophages, P = 0.0495) (Fig. 4B).  
These results indicate that small round cells and microglia are similar in 




Proliferation and differentiation of LN cells in the presence of M-CSF 
To examine the humoral factors necessary for the differentiation of LN cells 
into microglia, we cultured LN cells with the supernatant of the primary mixed 
glial culture for 7 d.  Most of the LN cells cultured with this supernatant 
(LN-Sup cells) were flat in shape and expressed CD11b, Iba1, TREM2, and IAb 
(Fig. 5A). 
Next, we measured the concentrations of cytokines in the supernatant of the 
primary mixed glial culture using the Bio-Plex Cytokine Assay System.  Among 
the assayed cytokines, the concentrations of M-CSF, VEGF, and TNF-α were 
remarkably high (614.2 ± 121.5 S.D. pg/ml of M-CSF, 2349.4 ± 845.9 S.D. pg/ml 
of VEGF, and 585.5 ± 278.2 S.D. pg/ml of TNF-α) compared with those of the 
other cytokines (Fig. 5B).  IL-2, IL-4, IL-5, and GM-CSF were not detected, and 
the concentrations of IL-1β, IL-10, IFN-γ, IL-15, FGF-basic, and MIG were very 
low (24.8 ± 10.7 S.D. pg/ml of IL-1β, 12.4 ± 6.9 S.D. pg/ml of IL-10, 18.0 ± 13.0 
S.D. pg/ml of IFN-γ, 34.4 ± 12.5 S.D. pg/ml of IL-15, and 21.6 ± 11.9 S.D. pg/ml 
of FGF-basic).  The concentrations of IL-18, LIF, MIP-2, and PDGF-BB were at 
an intermediate level (61.9 ± 23.3 S.D. pg/ml of IL-18, 92.5 ± 23.8 S.D. pg/ml of 
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LIF, 34.7 ± 11.6 S.D. pg/ml of MIG, 57.0 ± 31.6 S.D. pg/ml of MIP-2, and 115.7 ± 
36.1 S.D. pg/ml of PDGF-BB). 
To investigate the effect of each cytokine on the differentiation of LN cells, 
we cultured LN cells with M-CSF, VEGF, or TNF-α for 7 d.  All the LN cells 
cultured with M-CSF (LN-MCSF cells) were CD11b- and TREM2-positive (Fig. 
5C).  Morphologically, most LN-MCSF cells showed flat shapes on confocal 
microscopy (Fig. 5D).  The number of LN cells cultured with TNF-α (LN-TNF 
cells) or with VEGF (LN-VEGF cells) were very few, although these cells 
expressed CD11b and TREM2 (Fig. 5C). 
Next, LN cells were cultured with the mixed glial culture supernatant 
containing neutralizing antibodies of M-CSF, TNF-α, or VEGF.  Addition of the 
anti-VEGF antibody or anti-TNF-α antibody resulted in no change in the 
morphology or surface markers as compared with the culture containing the 
control antibodies; however, the addition of anti-M-CSF antibodies remarkably 
reduced the cell number despite the expression of TREM2 (Fig. 5C).  
 
 
Cell-to-cell contact between microglia and astrocytes 
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In order to reveal the role of cell-to-cell contact between microglia and other 
glial cells, especially astrocytes, in the differentiation of LN cells to microglia, we 
performed immunostaining of the mixed glial culture with LN cells by anti-GFAP 
antibody followed by secondary rhodamine-conjugated antibody against 
rabbit-IgG.  Analysis by confocal microscopy revealed that LN cell-derived 
small round cells were positioned above the GFAP-positive astrocytes (Fig. 6).  




Microglia, the immune cells of the CNS, exist in 3 distinct forms—amoeboid, 
ramified, and reactive microglia.  Ramified microglia are present in the brain 
parenchyma and constitute approximately 10–20% of the total population of glial 
cells in an adult (Vaughan & Peters, 1974; Banati, 2003).  Ramified microglia 
are small round cells comprising branching processes and are considered to be 
functionally inactive.  Further, they are known to express TREM2 in vivo 
(Schmid et al., 2002; Sessa et al., 2004) but not MHC class II (Santambrogio et al., 
2001; Servet-Delprat et al., 2002).  Recently, HSP60 has been identified as the 
ligand of TREM2, and its interaction with microglia has been demonstrated to 
stimulate microglial phagocytosis (Stefano et al., 2009).  This result indicates 
that TREM2 might play an important role in physiological phagocytosis as one of 
the microglia-specific functions.  TREM2 expression on small round cells in 
primary mixed glial culture might indicate that small round cells have greater 
mobility as microglia than do large flat cells in patrolling the brain environment in 
order to identify HSP60-expressing cells.  Moreover, as shown in Figure 4A, 
small round cells weakly expressed MHC class II molecules similar to brain 
microglia.  These results support our hypothesis that small round microglia in 
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vitro differentiated to a greater extent than did large flat cells.  Consistent with 
the results of the current study, previous studies have reported 2 different 
morphological shapes of microglia in primary mixed glial culture cells derived 
from mice (Saura et al., 2003) and rats (Tanaka et al., 1999; Kuwabara et al., 
2003).  In another study, the kinetic analysis of rat primary mixed glial culture 
demonstrated that “amoeboid” or “round” cells appeared during the early stages 
of the culture and that the majority of ramified microglia were formed after the 
complete formation of the astrocyte monolayer (Tanaka et al., 1999).  We 
demonstrated that LN cells directly differentiated into small round microglia-like 
cells without the intermediary formation of large flat precursors.  Although 
Ly-6Chigh Gr-1+CCR2+ monocytes in the peripheral blood have been reported to 
be the precursors of adult murine microglia (Mildner et al., 2007; Getts et al., 
2008), the LN cells in our study did not express CCR2 or Gr-1 (the anti-Gr-1 
antibodies used in this study also reacted with Ly-6C).  The role of CCR2, a 
crucial chemokine receptor for the chemotactic attraction of monocytes or 
macrophages during CNS inflammation, has been investigated in animal models 
of multiple sclerosis, such as experimental autoimmune encephalomyelitis (Fife et 
al., 2000; Izikson et al., 2000).  However, the physiological development and 
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functions of microglia are independent of CCR2 expression (Mildner et al., 2007).  
Since the absence of CCR2 expression is highly related to the Ly-6Chigh 
subpopulation (Mildner et al., 2007), Ly-6C may play a more important role than 
CCR2 in microglial differentiation.  It is unclear why the LN cells differentiated 
into small round microglia-like cells despite the lack of Ly-6C and Gr-1 
expression, but we hypothesize that the blood-brain barrier plays a key role in the 
differentiation of LN cells.  Indeed, Ly-6C is known to regulate endothelial 
adhesion and the homing of CD8+T cells by activating integrin-dependent 
adhesion pathways (Hänninen et al., 1997). 
  On the other hand, the LN cells in the current study did not differentiate 
into flat cells as the precursors of small round microglia.  Since they were first 
described by del Rio-Hortega (1932), the developmental origin of microglia has 
not been completely elucidated.  It is widely hypothesized that microglia are 
derived from myeloid lineage precursors and/or hematopoietic precursors during 
CNS development.  The fact that the formation of microglia occurs before the 
onset of vascularization in the developing brain (Wang et al., 1996) suggests that 
hematopoietic stem cells, which act as precursors to microglia during 
development, may be more primitive than precursor LN cells.  Therefore, it is 
 26
likely that the LN cells adopt a different pathway to differentiate into small round 
microglia-like cells. 
The supernatant of the primary mixed glial cultures derived from mice 
contains many cytokines such as M-CSF, VEGF, and TNF-α.  Our study showed 
that M-CSF plays an important role in the differentiation and proliferation of LN 
cells.  TREM2 is a unique molecule that is only expressed on microglia, 
osteoclasts, and immature dendritic cells (Colonna, 2003), while other 
microglia-specific markers such as Iba1 and CD11b are also expressed on 
macrophages and monocytes.  Since TREM2 was not expressed on the mature 
dendritic cells or the activated microglia (macrophages), it is likely that TREM2 
expression may be restricted to the immature stages of myeloid lineage cells.  In 
our study, M-CSF induced the proliferation of LN cells and the expression of not 
only CD11b and Iba1 but also TREM2 on LN cells; this indicates that M-CSF 
determines the differentiation of LN cells into the myeloid lineage, but not into 
fully differentiated cells.  Although the addition of anti-M-CSF antibodies 
appears not to suppress the expression of TREM2 on the LN cells, these TREM2+ 
cells may have originated from more mature precursors that are independent of 
M-CSF.  These immature LN cells would eventually be fully differentiated under 
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physiological conditions.  When LN cells were cultured with M-CSF, the number 
of small round cells in the culture was considerably low, indicating that the small 
round morphology of the immature cells is not maintained in the presence of only 
M-CSF.  On the other hand, when LN cells were grown in the presence of other 
glial cells (especially astrocytes), the small round cells were maintained at a 
concentration of approximately 30% of the total population.  Therefore, cell-cell 
contact with glial cells, especially astrocytes, may be necessary to maintain the 
small round shape of immature cells expressing TREM2.  
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BME, basal medium Eagle; CNS, central nervous system; DAPI, 
4′,6-diamidino-2-phenylindole; FCS, fetal calf serum; FITC, fluorescein 
isothiocyanate; GFAP, glial fibrillary acidic protein; GFP, green fluorescence 
protein; LN cells, lineage-negative bone marrow cells; M-CSF, macrophage 
colony stimulating factor; MHC, major histocompatibility complex; PE, 
phycoerythrin; TNF-α, Tumor Necrosis Factor-α; TREM2, triggering receptor 
expressing on myeloid cells-2; VEGF, vascular endothelial growth factor. 
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Morphology of microglia in primary mixed glial culture.  A, Immunocytology of 
primary mixed glial culture stained with anti-Iba1, anti-TREM2, anti-IAb, 
anti-CD11b, and 4′,6-diamidino-2-phenylindole (DAPI).  Arrowheads indicate 
small round cells.  Arrows indicate large flat cells.  Bar: 50 μm.  B, The 
percentage of round cells or flat cells among staining-positive cells was quantified 
by microscopic analysis.  Data are presented as mean ± standard deviation (S.D.).  
C, The percentage of Iba-1-, TREM2-, or IAb-positive cells among 
CD11b-positive (CD11b+) round or flat cells was quantified by microscopic 
analysis.  Data are presented as mean ± S.D.  D, Z-stack immunofluorescence 
confocal microscopy of primary mixed glial culture stained with anti-CD11b (red), 
anti-GFAP (green), and DAPI (blue).  Bar: 10 μm.  E, Z-stack 
immunofluorescence confocal microscopy of primary mixed glial culture stained 
with anti-CD11b (red), anti-GFAP (green), and DAPI (blue).  Bar: 10 μm.  F, 
Immunocytology of primary mixed glial culture.  Cultures were fixed at days 1, 
3, 5, and 7 of the culture and stained with primary anti-CD11b and anti-GFAP 
antibodies followed by rhodamine- or FITC-conjugated secondary antibody and 
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DAPI.  Arrowheads indicate small round cells.  Bar: 50 μm.  G, The 
percentage of CD11b+ round or flat cells was quantified by microscopic analysis.  




Flow cytometry analysis of lineage-negative bone marrow (LN) cells.  A, Flow 
cytometry analysis of LN cells (filled histogram) and bone marrow cells (open 
histogram) stained with rat monoclonal antibodies against mice lineage markers 
(CD3, CD4, CD5, CD8α, CD11b/MAC-1α, B220, Gr-1, and TER-119).  
Numbers above the lines indicate the percentage of LN cells.  B, Flow cytometry 
analysis of LN cells.  Filled histograms, staining with antibodies to markers 
below plots; Open histograms, isotype-matched control antibody.  Data are 
representative of three independent experiments. 
 
Figure 3. 
Lineage-negative bone marrow (LN) cells co-cultured with primary mixed glial 
culture.  A, Immunocytology of LN cells derived from GFP mice co-cultured 
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with primary mixed glial culture.  Cultures were stained with primary anti-Iba1, 
anti-TREM2, anti-IAb, and anti-CD11b antibodies followed by rhodamine- or 
Cy3-conjugated secondary antibody and DAPI.  Arrows indicate double-positive 
cells.  White arrowheads indicate GFP-negative rhodamine- or Cy3-positive cells.  
Red arrowheads indicate GFP-positive (GFP+) rhodamine- or Cy3-negative cells.  
Bar: 50 μm.  B, Percentage of round or flat cells among GFP+ cells or 
double-positive cells.  Data are presented as mean ± S.D.  C, Z-stack 
immunofluorescence confocal microscopy of LN cells derived from GFP mice 
co-cultured with primary mixed glial culture stained with anti-TREM2 (red) and 
DAPI (blue).  GFP and TREM2 double-positive cells show a spherical shape.  
Bar: 10 μm.  D, Phosphorylation of ERK after cross-linking stimulation of 
LN cell derived small round cells by flow cytometry.  Red line histograms, 
stimulated with anti-TREM2 antibody; Blue line histograms, stimulated with 
control antibody; Filled histograms, stained with isotype-matched control 
antibody.  Data are representative of three independent experiments.  E, 
Immunocytology of LN cells derived from GFP mice co-cultured with primary 
mixed glial culture.  Cells were fixed at days 1, 7, and 14 after co-culture and 
stained with primary anti-TREM2 or anti-Iba1 antibodies followed by 
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rhodamine-conjugated secondary antibody and DAPI.  Arrows indicate GFP and 
TREM2/Iba1 double-positive cells.  Arrowheads indicate GFP+ and 
rhodamine-negative cells.  Bar: 50 μm.  F, Percentage of round or 
amoeboid/flat cells among GFP+ cells was quantified by microscopic analysis.  
The proportion of small round and amoeboid/flat cells of GFP+ cells showed no 
changes at days 1 and 7, but the number of small round cells reduced at day 14.  
Data are presented as mean ± S.D. *, P < 0.05.  Data are representative of three 
independent experiments. 
 
Figure 4.  
Surface cell markers and proliferative capacity of lineage-negative bone marrow 
(LN) cell-derived small round cells.  A, Flow cytometry analysis of cultured 
microglia, LN cell-derived small round cells, brain microglia, and splenic 
macrophages.  Open histograms, staining with antibodies to markers below plots; 
Filled histograms, isotype-matched control antibody.  Data are representative of 
three independent experiments.  B, Proliferative capacity of cultured microglia, 
LN cell-derived small round cells, brain microglia, and splenic macrophages.  
Proliferation was measured by thymidine incorporation.  Data are presented as 
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Proliferation and expression of TREM2 on lineage-negative bone marrow (LN) 
cells in the presence of M-CSF.  A, Immunocytology of LN cells cultured with 
supernatant of primary mixed glial culture.  Cultures were stained with anti-Iba1, 
anti-TREM2, anti-IAb, anti-CD11b, and DAPI.  Bar: 50 μm.  B, Analysis of 
concentration of cytokines (IL-1b, IL-2, IL-4, IL-5, IL-10, GM-CSF, IFN-γ, 
TNF-α, IL-15, IL-18, FGF-basic, LIF, M-CSF, MIG, MIP-2, PDGF-BB, and 
VEGF) in the supernatant of primary mixed glial culture by using the Bio-Plex 
Cytokine Assay System.  ND; not detectable.  Data are presented as mean ± 
S.D. of 12 independent experiments.  C, Immunocytology of LN cells cultured 
with M-CSF-, VEGF-, or TNF-α-containing medium and anti-MCSF, anti-VEGF, 
or anti TNF-α antibody-containing supernatant of mixed glial culture.  The cells 
were stained with anti-TREM2 antibodies, CD11b antibodies, and DAPI.  LN 
cells cultured with M-CSF showed no change in their morphology or surface 
markers as compared with LN cells cultured with the supernatant of primary 
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mixed glial culture; however, the addition of anti-M-CSF antibodies remarkably 
reduced the cell number.  Bar: 50 μm.  D, The percentage of spherical or flat 
cells was quantified by confocal microscopy.  Data are presented as mean ± S.D. 
*, P < 0.05.  Data are representative of three independent experiments. 
 
Figure 6. 
Z-stack immunofluorescence confocal microscopy of lineage-negative bone 
marrow cells derived from GFP mice co-cultured with primary mixed glial culture 
stained with anti-GFAP (red) and DAPI (blue).  Bar: 10 μm. 






